Pricing & Contracting USA 2026

Pricing & Contracting USA focuses on fostering collaboration among Medicaid, Commercial, and Government Teams to drive comprehensive market strategies within the life sciences industry. The event unites thought-leaders in policy, pricing, contracting, and reporting. Attendees can expect an upgraded program covering cutting-edge topics including Medicaid, Government Pricing and Policy, Drug Price Transparency, 340B, and Chargeback Management. Key insights for 2026 include Most Favored Nation (MFN) Pricing Implementation, Medicare Part B Drug Negotiations (2028 Launch), 340B Rebate Model from all stakeholder perspectives, State Medicaid Revenue Transparency Sessions, Cell & Gene Therapy Outcomes-Based Contracting, AI-Powered Pricing Scenario Planning, Direct-to-Consumer Pharma Initiatives, Chargeback Data Accuracy Impact on Rebates, updates on GTN, GPOs, PBMs, PDABs, and SPTR, and the impact of Government Shutdown Policy Timeline Disruption. The conference offers over 50 expert-led sessions, features more than 115 speakers, hosts 35+ sponsors and exhibitors, and provides 10 hours of dedicated networking opportunities.